{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:47:04Z","timestamp":1791233224943,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00266-026-05978-x","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:31:56Z","timestamp":1781278316000},"page":"6564-6570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9046-9201","authenticated-orcid":false,"given":"Agostino","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Calicchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Schirosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"1","key":"5978_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jim-2021-001952","volume":"70","author":"G Singh","year":"2022","unstructured":"Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): a new weight loss drug for chronic weight management. J Investig Med. 2022;70(1):5\u201313. https:\/\/doi.org\/10.1136\/jim-2021-001952.","journal-title":"J Investig Med"},{"issue":"1","key":"5978_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/dom.14863","volume":"25","author":"NC Bergmann","year":"2023","unstructured":"Bergmann NC, Davies MJ, Lingvay I, Knop FK. Semaglutide for the treatment of overweight and obesity: a review. Diabetes Obes Metab. 2023;25(1):18\u201335. https:\/\/doi.org\/10.1111\/dom.14863.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"5978_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/87551225221137493","volume":"39","author":"G Huynh","year":"2023","unstructured":"Huynh G, Runeberg H, Weideman R. Evaluating weight loss with semaglutide in elderly patients with type II diabetes. J Pharm Technol. 2023;39(1):10\u20135. https:\/\/doi.org\/10.1177\/87551225221137493.","journal-title":"J Pharm Technol"},{"issue":"7","key":"5978_CR4","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","volume":"30","author":"DH Ryan","year":"2024","unstructured":"Ryan DH, Lingvay I, Deanfield J, Kahn SE, Barros E, Burguera B, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the select trial. Nat Med. 2024;30(7):2049\u201357. https:\/\/doi.org\/10.1038\/s41591-024-02996-7.","journal-title":"Nat Med"},{"issue":"9","key":"5978_CR5","doi-asserted-by":"publisher","first-page":"e2231982","DOI":"10.1001\/jamanetworkopen.2022.31982","volume":"5","author":"W Ghusn","year":"2022","unstructured":"Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, et al. Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Netw Open. 2022;5(9):e2231982. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.31982.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"5978_CR6","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.3390\/cimb46120872","volume":"46","author":"I Papakonstantinou","year":"2024","unstructured":"Papakonstantinou I, Tsioufis K, Katsi V. Spotlight on the mechanism of action of semaglutide. Curr Issues Mol Biol. 2024;46(12):14514\u201341. https:\/\/doi.org\/10.3390\/cimb46120872.","journal-title":"Curr Issues Mol Biol"},{"issue":"36","key":"5978_CR7","doi-asserted-by":"publisher","first-page":"100340","DOI":"10.1016\/j.jcte.2024.100340","volume":"28","author":"H Yaribeygi","year":"2024","unstructured":"Yaribeygi H, Maleki M, Jamialahmadi T, Sahebkar A. Anti-inflammatory benefits of semaglutide: State of the art. J Clin Transl Endocrinol. 2024;28(36):100340. https:\/\/doi.org\/10.1016\/j.jcte.2024.100340.","journal-title":"J Clin Transl Endocrinol"},{"issue":"2","key":"5978_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/apt.15316","volume":"50","author":"P Newsome","year":"2019","unstructured":"Newsome P, Francque S, Harrison S, Ratziu V, Van Gaal L, Calanna S, et al. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 Diabetes and\/or Obesity. Aliment Pharmacol Ther. 2019;50(2):193\u2013203. https:\/\/doi.org\/10.1111\/apt.15316.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6706","key":"5978_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1126\/science.adn4128","volume":"385","author":"DJ Drucker","year":"2024","unstructured":"Drucker DJ. The benefits of GLP-1 drugs beyond obesity. Science. 2024;385(6706):258\u201360. https:\/\/doi.org\/10.1126\/science.adn4128.","journal-title":"Science"},{"issue":"2","key":"5978_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.15605\/jafes.037.02.14","volume":"37","author":"HC Tan","year":"2022","unstructured":"Tan HC, Dampil OA, Marquez MM. Efficacy and safety of semaglutide for weight loss in obesity without diabetes: a systematic review and meta-analysis. J ASEAN Fed Endocr Soc. 2022;37(2):65\u201372. https:\/\/doi.org\/10.15605\/jafes.037.02.14.","journal-title":"J ASEAN Fed Endocr Soc."},{"issue":"4","key":"5978_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.14797\/mdcvj.1248","volume":"19","author":"RM Sanchez Leon","year":"2023","unstructured":"Sanchez Leon RM, Rajaraman A, Kubwimana MN. Optimizing nutritional status of patients prior to major surgical intervention. Methodist Debakey Cardiovasc J. 2023;19(4):85\u201396. https:\/\/doi.org\/10.14797\/mdcvj.1248.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"4","key":"5978_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/asj\/sjae241","volume":"45","author":"JE Lewis","year":"2025","unstructured":"Lewis JE, Ghogomu M, Hickman SJ, Ashade A, Hollis RJ, Lewis JE 3rd, et al. Semaglutide and postoperative outcomes in nondiabetic patients following body contouring surgery. Aesthet Surg J. 2025;45(4):381\u20136.","journal-title":"Aesthet Surg J"},{"issue":"10","key":"5978_CR13","doi-asserted-by":"publisher","first-page":"996179","DOI":"10.3389\/fpubh.2022.996179","volume":"20","author":"Y Shu","year":"2022","unstructured":"Shu Y, He X, Wu P, Liu Y, Ding Y, Zhang Q. Gastrointestinal adverse events associated with semaglutide: a pharmacovigilance study based on FDA adverse event reporting system. Front Public Health. 2022;20(10):996179. https:\/\/doi.org\/10.3389\/fpubh.2022.996179.","journal-title":"Front Public Health"},{"issue":"5","key":"5978_CR14","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.bja.2024.10.013","volume":"134","author":"H Huang","year":"2025","unstructured":"Huang H, Hu C, Liu F, Ji F, Fu Y, Cao M. Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system. Br J Anaesth. 2025;134(5):1486\u201396. https:\/\/doi.org\/10.1016\/j.bja.2024.10.013.","journal-title":"Br J Anaesth"},{"issue":"6","key":"5978_CR15","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s00266-023-03775-4","volume":"48","author":"H Kandulu","year":"2024","unstructured":"Kandulu H. Weight loss after VASER-assisted liposuction. Aesthetic Plast Surg. 2024;48(6):1166\u201373. https:\/\/doi.org\/10.1007\/s00266-023-03775-4.","journal-title":"Aesthetic Plast Surg"},{"key":"5978_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/5584_2020_496","volume":"1307","author":"DB Maselli","year":"2021","unstructured":"Maselli DB, Camilleri M. Effects of GLP-1 and Its analogs on gastric physiology in diabetes mellitus and obesity. Adv Exp Med Biol. 2021;1307:171\u201392.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"5978_CR17","doi-asserted-by":"publisher","first-page":"e42153","DOI":"10.7759\/cureus.42153","volume":"15","author":"E Fujino","year":"2023","unstructured":"Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus. 2023;15(7):e42153. https:\/\/doi.org\/10.7759\/cureus.42153.","journal-title":"Cureus."},{"issue":"5","key":"5978_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/nu13051675","volume":"13","author":"KR Hirsch","year":"2021","unstructured":"Hirsch KR, Wolfe RR, Ferrando AA. Pre- and Post-surgical nutrition for preservation of muscle mass, strength, and functionality following Orthopedic surgery. Nutrients. 2021;13(5):1675. https:\/\/doi.org\/10.3390\/nu13051675.","journal-title":"Nutrients"},{"issue":"8","key":"5978_CR19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/nu14081601","volume":"14","author":"AJ Mart\u00ednez-Ortega","year":"2022","unstructured":"Mart\u00ednez-Ortega AJ, Pi\u00f1ar-Guti\u00e9rrez A, Serrano-Aguayo P, Gonz\u00e1lez-Navarro I, Rem\u00f3n-Ru\u00edz PJ, Pereira-Cunill JL, et al. Perioperative nutritional support: a review of current literature. Nutrients. 2022;14(8):1601. https:\/\/doi.org\/10.3390\/nu14081601.","journal-title":"Nutrients"},{"issue":"1","key":"5978_CR20","doi-asserted-by":"publisher","first-page":"e5516","DOI":"10.1097\/GOX.0000000000005516","volume":"12","author":"ES O'Neill","year":"2024","unstructured":"O\u2019Neill ES, Wiegmann AL, Parrella N, Pittman T, Hood K, Kurlander D. Injectable weight loss medications in plastic surgery: what we know, perioperative considerations, and recommendations for the future. Plast Reconstr Surg Glob Open. 2024;12(1):e5516. https:\/\/doi.org\/10.1097\/GOX.0000000000005516.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"5978_CR21","doi-asserted-by":"publisher","first-page":"156113","DOI":"10.1016\/j.metabol.2024.156113","volume":"164","author":"P Karakasis","year":"2025","unstructured":"Karakasis P, Patoulias D, Fragakis N, Mantzoros CS. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism. 2025;164:156113. https:\/\/doi.org\/10.1016\/j.metabol.2024.156113.","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"5978_CR22","doi-asserted-by":"publisher","first-page":"A16","DOI":"10.1210\/jendso\/bvab048.030","volume":"5","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Van Gaal LF, McGowan BM, Rosenstock J, et al. Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the step 1 study. J Endocr Soc. 2021;5(Suppl 1):A16\u20137. https:\/\/doi.org\/10.1210\/jendso\/bvab048.030.","journal-title":"J Endocr Soc."},{"key":"5978_CR23","unstructured":"American Society of Anesthesiologists. GLP-1 receptor agonists and perioperative care. 2023. Available from: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/glp1-receptor-agonists-perioperative-guidance."},{"issue":"1","key":"5978_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/archsurg.134.1.36","volume":"134","author":"J Gibbs","year":"1999","unstructured":"Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical risk study. Arch Surg. 1999;134(1):36\u201342. https:\/\/doi.org\/10.1001\/archsurg.134.1.36.","journal-title":"Arch Surg"},{"issue":"2","key":"5978_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/SLA.0b013e3181e9819a","volume":"252","author":"DB Hennessey","year":"2010","unstructured":"Hennessey DB, Burke JP, Ni-Dhonochu T, Shields C, Winter DC, Mealy K. Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery: a multi-institutional study. Ann Surg. 2010;252(2):325\u20139. https:\/\/doi.org\/10.1097\/SLA.0b013e3181e9819a.","journal-title":"Ann Surg"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-026-05978-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:16:52Z","timestamp":1787231812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-026-05978-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":25,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5978"],"URL":"https:\/\/doi.org\/10.1007\/s00266-026-05978-x","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each participant has given written informed consent for publication.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}